Back

Session conclusion and take home messages.

31 August 2020 (19:28 - 19:30)
Organised by:
Congress Presentation Part of: Medtronic Leading with Evidence: Latest data from Evolut TAVI and Renal Denervation Treatment Open Access ESC Congress 2020

About the speaker

Photo
Doctor Jeffrey Popma

Beth Israel Deaconess Medical Center, Boston (United States of America)

5 More presentations in this session

Presentation thumbnail
Introduction and learning objectives.
Doctor J. Popma (Boston, US)
Video
Presentation thumbnail
Paradigm shifting evidence in TAVI – Evolut low risk trial and sub analyses.
Doctor J. Popma (Boston, US)
Video
Presentation thumbnail
The importance of valve hemodynamics – Why should it be a priority in TAVI?
Professor M. Abdel-Wahab (Leipzig, DE)
Video
Presentation thumbnail
A Pivotal moment for renal denervation.
Professor M. Boehm (Homburg, DE)
Video
Presentation thumbnail
Addressing the Population Question: Who is the Renal Denervation Patient?
Professor A. Pathak (Luxembourg, LU)
Video

Access the full session

Session thumbnail
Medtronic Leading with Evidence: Latest data from Evolut TAVI and Renal Denervation
Video

The Event

Event poster

ESC Congress 2020

31 August 2020 19:28 CET
You may be interested in
thumbnail
Congress Presentation
What is new in hypertension: highlights from the 2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension
thumbnail
Congress Presentation
When to start drug treatment and new blood pressure treatment targets
thumbnail
Congress Presentation
Add-on treatment with zilebesiran for inadequately controlled hypertension: KARDIA-2 RCT

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources